Strategies for Life Sciences Firms in a Bear Market

December 12, 2008

Krist Werling and Bart Walker of McGuireWoods LLP co-hosted a complimentary webinar with Frank Stokes, Managing Director, Robert W. Baird & Co., Inc. and Scott Weiner, Principal, Pappas Ventures, on December 11, 2008. The event discussed how the credit crunch has created significant issues for life science companies seeking to grow. The inability to raise funds through an initial public offering, combined with the exit of major private equity funds from the market, has forced growing biotech and medical device companies to stay private longer and seek alternative financing. This is creating a significant upswing in merger and acquisition and partnership activities within the life science market. The panel covered the following points:

  • Collaboration strategies between public and private life science firms
  • Predictions for the 2009 biotech and device M&A activities
  • Strategies for attracting funding from diverse public and private sources
  • Alternative financing routes and creative deal structures

Download available:

  • Audio – MP3 (15.6mb)